Tandem Diabetes Care, Inc. develops and manufactures automated insulin delivery systems for the management of diabetes. Its primary products include the Tandem Mobi insulin pump and the t:slim X2 insulin pump, both of which utilize Control-IQ+ technology to predict and manage blood glucose levels. The company serves individuals with type 1 and type 2 diabetes, offering solutions that integrate with continuous glucose monitors and mobile applications for enhanced diabetes management. Tandem operates primarily in the United States.
